CHICAGO, April 24, 2024 /PRNewswire/ -- The Beta-Glucan
Market is estimated at USD 542
million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from
2024 to 2029 according to a report published by
MarketsandMarkets™. The growth of the beta-glucan market is
being fueled by factors like the growing demand for natural food
additives in the food and beverage industry and the increasing
utilization of beta-glucan in pharmaceutical tablets and capsules.
Additionally, the rising trend of incorporating beta-glucan in
cosmetic products to enhance emulsification is contributing to
market expansion.
Download PDF
Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796
Browse in-depth TOC on "Beta-Glucan Market"
70 – Tables
60 – Figures
350 –
Pages
By source, the yeast segment is expected to grow at a faster
rate during the forecast period 2024-2029.
Yeast has emerged as a leading and rapidly growing source for
the beta-glucan market due to its efficiency in producing
high-quality beta-glucans at a fast rate. Yeast plays a pivotal
role in industrial fermentation processes, contributing to the
production of a range of products like bread, beer, and biofuels.
Efficient and speedy growth of yeast is essential for large-scale
industrial cultivation to meet production requirements. In
industrial settings, yeast strains are frequently tailored for
rapid growth rates, including the production of beta-glucans,
thereby bolstering yeast's potential as a prolific source of
beta-glucan, and they have gained significant attention for their
health-promoting properties, including immune system modulation and
cholesterol-lowering effects. Yeast, particularly species like
Saccharomyces cerevisiae, offers several advantages in beta-glucan
production, including scalability, consistent quality, and
cost-effectiveness. Moreover, advancements in biotechnological
processes and genetic engineering have further enhanced yeast's
potential as a sustainable and efficient source for beta-glucan
production, positioning it at the forefront of the expanding
beta-glucan market.
By application dietary supplement segment is expected to grow
fastest during the forecast period
Yeast is crucial in industrial fermentation processes,
facilitating the production of diverse products such as bread,
beer, and biofuels. Rapid and efficient yeast growth is vital for
meeting the demands of large-scale industrial production. In these
industrial environments, yeast strains are often optimized for fast
growth, which includes enhancing the production of beta-glucans,
reinforcing yeast's capacity as a significant source of
beta-glucan. Swisse Wellness, an Australian health and wellness
firm, introduced the Beta-Immune Booster, a dietary supplement
featuring beta-glucan derived from the yeast Saccharomyces
cerevisiae. Marketed to bolster immune function, the product
debuted in 2021 and has garnered favorable feedback from users.
This launch highlights the rising interest in and demand for
beta-glucan supplements as consumers increasingly turn to natural
and potent dietary aids. This trend suggests a promising future for
beta-glucan products in the marketplace.
Request Sample
Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=5191796
The North American market is projected to contribute the
largest share for the beta-glucan market
The North American beta-glucan market is driven by its extensive
use in various products and their associated health benefits. Key
players in this market segment in North
America include Merck (US) and Lesaffre (US). Advancements
in technology have expanded the applications of beta-glucan in the
food & beverage industry, where it is utilized as thickening
agents, fat substitutes, dietary fiber, and hypocholesterolemic
agents, thereby fostering growth in the region.
In the US, consumer preferences are shifting towards low-calorie
and low-fat food options due to increased calorie-consciousness.
The rising incidence of obesity and cardiovascular diseases has
fueled demand for natural and low-calorie ingredient-based food
products. Data from the Centre for Disease Control & Prevention
(CDC) and the National Health and Nutrition Examination Survey
(2021-2022) indicates that the adult obesity rate has surged to
42.4% in 2020-2021.
The rise in incidences of obesity, heart diseases, diabetes, and
other health issues has led to a surge in demand for healthy
ingredient-based products manufactured. Consumers in North America are gradually becoming aware of
the health benefits of oat beta-glucan and its significance in
enhancing body immunity. This, in turn, is projected to drive the
growth of the beta-glucan market in this region. The growth of the
food industry and the increase in the usage of healthy food
ingredients and additives in Canada and Mexico have contributed to the growth of the
beta-glucan market in North
America. Food manufacturers are therefore concentrating on
different applications of beta-glucan products.
Tate & Lyle PLC (UK), Kerry Group plc (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), Lesaffre
(France), Kemin Industries (US),
Angel Yeast Co. Ltd (China),
Lallemand (Canada), Associated
British Foods Plc (UK), Bigrigin (Brazil), Ceapro, Inc. (Canada), NutriScience Innovations, LLC (US),
Alltech (US), Garuda International Inc. (US), and Leiber (Germany) are the key players in the
beta-glucan market.
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=5191796
Browse Adjacent Reports @ Food and Beverage Market Research
Reports & Consulting
Related Reports:
Feed Yeast Market by Type (Yeast Derivatives, Probiotic
Yeast, Brewer's Yeast, and Specialty Yeast), Livestock (Ruminants,
Swine, Poultry, Aquatic Animals, Pets and Equine), Genus , and
Region - Global Forecast to 2025
Specialty Yeast Market by Type (Yeast Extracts, Yeast
Autolysates, Yeast Beta-glucan, and Other Yeast Derivatives),
Species (Saccharomyces Cerevisiae, Pichia Pastoris, Kluyveromyces),
Application and Region – Global Forecast to 2027
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or
follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight:
https://www.marketsandmarkets.com/ResearchInsight/beta-glucan-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source:
https://www.marketsandmarkets.com/PressReleases/beta-glucan.asp
Logo:
https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/beta-glucan-market-worth-800-million-by-2029--exclusive-report-by-marketsandmarkets-302125653.html